Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab... see more

TSX:MBX - Post Discussion

View:
Post by RazeKreations on Jul 05, 2023 2:40pm

Invisible

I don't think many are even aware of Microbix anymore other than the ones posting here.  Volumne of trades has become almost non existent.  Such a difference from a couple of years ago. It could be like this until Kinlytic hits the market. And Microbix is not alone with that sentiment. The stock market is no friend to many smaller companies.  Controlled too much by computer trading
Comment by prophetoffactz on Jul 05, 2023 9:08pm
Once the expected value has been created microcaps can move at any time. A single fund manager could want in in size. A fund manager could tell the story on BNN. A takeover could be announced. A new analyst could cover the story. An old analyst could put it on a focus list. A news release could drive the message home. It's only a matter of time. Don't focus on the current share price ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities